Table 7.
Causality assessment of ADRs in the reference cohort.
| Scale | Causality Assessment | Other Antibiotics | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Ceftazidime | Cefuroxime | Piperacillin–Tazobactam | Amoxicillin–Clavulanic Acid | Metronidazole | Cefuroxime–Sulbactam | Ceftriaxone | |||
| WHO–UMC Criteria | Certain | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Probable/Likely | 0 | 1 | 0 | 4 | 0 | 0 | 1 | 46.2% (6) | |
| Possible | 1 | 0 | 1 | 2 | 2 | 1 | 0 | 53.9% (7) | |
| Naranjo Probability | Definite | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7.7% (1) |
| Probable | 0 | 1 | 0 | 4 | 0 | 0 | 1 | 46.2% (6) | |
| Possible | 1 | 0 | 1 | 1 | 2 | 1 | 0 | 46.2% (6) | |
| Hartwig’s Severity Assessment | Level 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Level 2 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 23.1% (3) | |
| Level 3 | 1 | 0 | 0 | 5 | 2 | 0 | 1 | 69.2% (9) | |
| Level 4a | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7.7% (1) | |
| Level 4b | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Level 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Level 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Level 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |